Search Results - Vivianna M. Van Deerlin

Refine Results
  1. 1
    Alzheimer’s Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing

    Alzheimer’s Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing by Jill Goldman, Vivianna M. Van Deerlin

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.

    The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. by Vivianna M. Van Deerlin, Douglas M. Tollefsen

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Adenomyosis: current concepts and imaging considerations.

    Adenomyosis: current concepts and imaging considerations. by Eric K. Outwater, Evan S. Siegelman, Vivianna M. Van Deerlin

    Published 1998
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Genetic Testing and Parkinson Disease: Assessment of Patient Knowledge, Attitudes, and Interest

    Genetic Testing and Parkinson Disease: Assessment of Patient Knowledge, Attitudes, and Interest by Dana Falcone, Elisabeth McCarty Wood, Sharon X. Xie, Andrew Siderowf, Vivianna M. Van Deerlin

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease

    Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease by John N. Lukens, Vivianna M. Van Deerlin, Christopher M. Clark, Sharon X. Xie, F. Brad Johnson

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Poly-A Binding Protein-1 Localization to a Subset of TDP-43 Inclusions in Amyotrophic Lateral Sclerosis Occurs More Frequently in Patients Harboring an Expansion in<i>C9orf72</i>

    Poly-A Binding Protein-1 Localization to a Subset of TDP-43 Inclusions in Amyotrophic Lateral Sclerosis Occurs More Frequently in Patients Harboring an Expansion in<i>C9orf72</i> by Leeanne McGurk, Virginia M. Lee, John Q. Trojanowksi, Vivianna M. Van Deerlin, Edward B. Lee, Nancy M. Bonini

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

    Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis by Johannes Brettschneider, Jon B. Toledo, Vivianna M. Van Deerlin, Lauren Elman, Leo McCluskey, Virginia M.‐Y. Lee, John Q. Trojanowski

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    TDP-43 skeins show properties of amyloid in a subset of ALS cases

    TDP-43 skeins show properties of amyloid in a subset of ALS cases by John Robinson, Felix Geser, Anna Stieber, Mfon Umoh, Linda K. Kwong, Vivianna M. Van Deerlin, Virginia M.‐Y. Lee, John Q. Trojanowski

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine

    Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine by David J. Irwin, Nigel J. Cairns, Murray Grossman, Corey T. McMillan, Edward B. Lee, Vivianna M. Van Deerlin, Virginia M.‐Y. Lee, John Q. Trojanowski

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies

    Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies by David J. Irwin, Todd J. Cohen, Murray Grossman, Steven E. Arnold, Elisabeth McCarty-Wood, Vivianna M. Van Deerlin, Virginia M.‐Y. Lee, John Q. Trojanowski

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

    C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD by Elaine Y. Liu, Jenny Russ, Kathryn Wu, Donald Neal, EunRan Suh, Anna G. McNally, David J. Irwin, Vivianna M. Van Deerlin, Edward B. Lee

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP Mutations

    Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP Mutations by Peter Kühnlein, Anne‐Dorte Sperfeld, Ben Vanmassenhove, Vivianna M. Van Deerlin, Virginia M.‐Y. Lee, John Q. Trojanowski, Hans A. Kretzschmar, Albert C. Ludolph, Manuela Neumann

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration

    Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration by Elisabeth McCarty Wood, Dana Falcone, EunRan Suh, David J. Irwin, Alice Chen‐Plotkin, Edward B. Lee, Sharon X. Xie, Vivianna M. Van Deerlin, Murray Grossman

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia

    Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia by Lucia Giannini, David J. Irwin, Corey T. McMillan, Sharon Ash, Katya Rascovsky, David A. Wolk, Vivianna M. Van Deerlin, Edward B. Lee, John Q. Trojanowski, Murray Grossman

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

    Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis by Leeanne McGurk, Jelena Mojsilovic‐Petrovic, Vivianna M. Van Deerlin, James Shorter, Robert G. Kalb, V. M. Lee, John Q. Trojanowski, E. B. Lee, Nancy M. Bonini

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Genetic prediction of impulse control disorders in Parkinson's disease

    Genetic prediction of impulse control disorders in Parkinson's disease by Daniel Weintraub, Marijan Posavi, Pierre Fontanillas, Thomas F. Tropea, Eugenia Mamikonyan, EunRan Suh, John Q. Trojanowski, Paul J. Cannon, Vivianna M. Van Deerlin, Alice Chen‐Plotkin

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Annexin A11 aggregation in FTLD–TDP type C and related neurodegenerative disease proteinopathies

    Annexin A11 aggregation in FTLD–TDP type C and related neurodegenerative disease proteinopathies by John Robinson, EunRan Suh, Yan Xu, Howard I. Hurtig, Lauren Elman, Corey T. McMillan, David J. Irwin, Sílvia Porta, Vivianna M. Van Deerlin, Edward B. Lee

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease

    CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease by Andrew Siderowf, Sharon X. Xie, Howard I. Hurtig, Daniel Weintraub, John E. Duda, Alice Chen‐Plotkin, Leslie M. Shaw, Vivianna M. Van Deerlin, John Q. Trojanowski, C. Clark

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy

    Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy by Felix Geser, Beth Stein, Michael Partain, Lauren Elman, Leo McCluskey, Sharon X. Xie, Vivianna M. Van Deerlin, Linda K. Kwong, Virginia M.‐Y. Lee, John Q. Trojanowski

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Reduced CSF p-Tau <sub>181</sub> to Tau ratio is a biomarker for FTLD-TDP

    Reduced CSF p-Tau <sub>181</sub> to Tau ratio is a biomarker for FTLD-TDP by William T. Hu, Kelly D. Watts, Murray Grossman, Jonathan D. Glass, James J. Lah, Chadwick M. Hales, Matthew Shelnutt, Vivianna M. Van Deerlin, John Q. Trojanowski, Allan I. Levey

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: